PDS Biotechnology Corp (PDSB)
3.29
+0.06
(+1.70%)
USD |
NASDAQ |
Nov 05, 14:45
PDS Biotechnology Price to Book Value: 3.918 for Nov. 5, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 04, 2024 | 3.852 |
| November 01, 2024 | 3.811 |
| October 31, 2024 | 3.799 |
| October 30, 2024 | 3.829 |
| October 29, 2024 | 3.835 |
| October 28, 2024 | 3.930 |
| October 25, 2024 | 3.716 |
| October 24, 2024 | 3.704 |
| October 23, 2024 | 3.710 |
| October 22, 2024 | 3.882 |
| October 21, 2024 | 3.716 |
| October 18, 2024 | 3.870 |
| October 17, 2024 | 3.692 |
| October 16, 2024 | 3.775 |
| October 15, 2024 | 3.847 |
| October 14, 2024 | 3.906 |
| October 11, 2024 | 4.073 |
| October 10, 2024 | 3.942 |
| October 09, 2024 | 4.049 |
| October 08, 2024 | 4.240 |
| October 07, 2024 | 4.442 |
| October 04, 2024 | 4.418 |
| October 03, 2024 | 4.716 |
| October 02, 2024 | 4.895 |
| October 01, 2024 | 4.347 |
| Date | Value |
|---|---|
| September 30, 2024 | 4.549 |
| September 27, 2024 | 4.013 |
| September 26, 2024 | 3.728 |
| September 25, 2024 | 3.608 |
| September 24, 2024 | 3.728 |
| September 23, 2024 | 3.739 |
| September 20, 2024 | 3.811 |
| September 19, 2024 | 3.823 |
| September 18, 2024 | 3.656 |
| September 17, 2024 | 3.716 |
| September 16, 2024 | 3.644 |
| September 13, 2024 | 3.573 |
| September 12, 2024 | 3.632 |
| September 11, 2024 | 3.692 |
| September 10, 2024 | 3.585 |
| September 09, 2024 | 3.585 |
| September 06, 2024 | 3.489 |
| September 05, 2024 | 3.573 |
| September 04, 2024 | 3.585 |
| September 03, 2024 | 3.596 |
| August 30, 2024 | 3.811 |
| August 29, 2024 | 3.751 |
| August 28, 2024 | 3.680 |
| August 27, 2024 | 3.716 |
| August 26, 2024 | 3.787 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.5012
Minimum
Apr 02 2020
13.63
Maximum
Jun 28 2021
3.823
Average
3.690
Median
Aug 17 2020
Price to Book Value Benchmarks
| Chimerix Inc | 0.6050 |
| Cellectar Biosciences Inc | 18.15 |
| Marinus Pharmaceuticals Inc | -- |
| Jaguar Health Inc | 0.5685 |
| Seres Therapeutics Inc | -- |
Price to Book Value Related Metrics
| Price | 3.29 |
| Earnings Yield | -37.39% |
| Market Cap | 121.14M |